Price
No data yet.
Social Signal Score
Revenue
$354.64M+702.63%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Scott R. Cutler
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 2,814
- Beta
- 0.21
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 5.13
Financials
Revenue
$354.64M+702.6%Net Income
$69.42M+743.2%EBITDA
$105.95M+565.7%Free Cash Flow
$97.16M+821.9%EPS (diluted)
$0.82+485.7%Shares Outstanding (diluted)
85.01M+42.5%Operating Expenses
$125.73MCash & Debt
$265.37MReturn of Capital
$123.31MRevenue by Segment (annual)
$1.31BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $1.31B | $215.20M | $2.50 |
| 2025 | $1.20B | $96.70M | $1.11 |
| 2024 | $999.59M | $55.71M | $0.65 |
| 2023 | $861.75M | $-26.14M | $-0.31 |
| 2022 | $756.56M | $-44.29M | $-0.53 |
| 2021 | $733.57M | $8.83M | $0.12 |
| 2020 | $531.99M | $39.66M | $0.59 |
| 2019 | $287.24M | $73.90M | $1.20 |
| 2018 | $229.53M | $47.36M | $0.79 |
| 2017 | $178.37M | $26.38M | $0.45 |
| 2016 | $126.79M | $16.61M | $0.29 |
| 2015 | $87.86M | $10.17M | $0.39 |
| 2014 | $62.02M | $1.23M | $-1.26 |
| 2013 | $46.09M | $11.17M | $0.51 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HQY's reported EPS growth of 13.0% a year over 13 years.
- EPS in 5 years
- $4.60
- Implied price
- $156.51
- Return from $105.28
- 8.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $77.81 — -26.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 24 | 29 | 34 | 39 | 44 |
|---|---|---|---|---|---|
| 3.0% | -8.0% | -4.4% | -1.3% | 1.4% | 3.9% |
| 8.0% | -3.5% | 0.2% | 3.5% | 6.3% | 8.9% |
| 13.0% | 1.0% | 4.9% | 8.3% | 11.3% | 14.0% |
| 18.0% | 5.4% | 9.5% | 13.0% | 16.2% | 19.0% |
| 23.0% | 9.9% | 14.1% | 17.8% | 21.1% | 24.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newszacks.com·5h ago·Neutral
Ahead of HealthEquity (HQY) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics Beyond analysts' top-and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2026.
View source ↗
Earnings
Thu, Aug 27(in 2 days)
Consensus estimate $1.19 per share
Typical surprise +10.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, May 28$1.24 vs $1.11beat
- Tue, Mar 17$0.95 vs $0.89beat
- Wed, Dec 3$1.01 vs $0.91beat
- Tue, Sep 2$1.08 vs $0.91beat
- Tue, Jun 3$0.97 vs $0.81beat
- Tue, Mar 18$0.69 vs $0.71miss
Estimates and results for HQY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HQY officers and directors.
- Bought
- —
- Sold
- $25.7m
0 trades
22 trades
- Fiore Michael Henrysold
- Fiore Michael Henrysold
- Fiore Michael Henrysold
- Wellborn Gayle Furgursonsold
- Ladd Delanosold
- Ladd Delanosold
- Rosner Elimelechsold
- Wellborn Gayle Furgursonsold
78 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.